{"id":5596,"date":"2023-04-16T06:20:44","date_gmt":"2023-04-16T06:20:44","guid":{"rendered":"https:\/\/blogs.sld.cu\/oserranob\/?p=5596"},"modified":"2023-04-16T06:20:44","modified_gmt":"2023-04-16T06:20:44","slug":"farmacogenetica-aspirina-esquizofrenia-farmacomicrobiomica-ansiedad-antidepresivos","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/oserranob\/2023\/04\/16\/farmacogenetica-aspirina-esquizofrenia-farmacomicrobiomica-ansiedad-antidepresivos\/","title":{"rendered":"Farmacogen\u00e9tica: aspirina, esquizofrenia, farmacomicrobi\u00f3mica, ansiedad, antidepresivos"},"content":{"rendered":"<p>&#8211; <a href=\"https:\/\/www.thieme-connect.com\/products\/ejournals\/html\/10.1055\/s-0042-1758445\">Impact of pharmacogenetics on aspirin resistance: a systematic review<\/a><br \/>\n&#8211; <a href=\"https:\/\/www.mdpi.com\/2075-4426\/13\/3\/471\">The Progress and Pitfalls of Pharmacogenetics-Based Precision Medicine in Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis<\/a><br \/>\n&#8211; <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/prm2.12095\">Integration of pharmacogenomic and pharmacomicrobiomic data for personalized medicine<\/a><br \/>\n&#8211; <a href=\"https:\/\/www.nature.com\/articles\/s41380-023-01998-0\">Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs<\/a><br \/>\n&#8211; <a href=\"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/abs\/10.1002\/cpt.2903\">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8211; Impact of pharmacogenetics on aspirin resistance: a systematic review &#8211; The Progress and Pitfalls of Pharmacogenetics-Based Precision Medicine in Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis &#8211; Integration of pharmacogenomic and pharmacomicrobiomic data for personalized medicine &#8211; Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs &#8211; Clinical [&hellip;]<\/p>\n","protected":false},"author":125,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[19,23,42,29,32],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/5596"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/comments?post=5596"}],"version-history":[{"count":1,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/5596\/revisions"}],"predecessor-version":[{"id":5597,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/5596\/revisions\/5597"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/media?parent=5596"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/categories?post=5596"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/tags?post=5596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}